SCHEMBL22010497

SCHEMBL22010497

Cc1oc2c(O)cccc2c1CN(C)C(=O)OC(C)(C)C

nearest known ligand 0.34

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HTR2C P28335 1/20 0.34
SLC6A4 P31645 1/20 0.34
APLNR P35414 1/20 0.34
GAA P10253 3/20 0.34
MEN1 O00255 1/20 0.34
NPC1 O15118 1/20 0.34
CYP1A2 P05177 1/20 0.34
CYP3A4 P08684 1/20 0.34
MAPT P10636 1/20 0.34
CYP2C9 P11712 1/20 0.34
CYP2C19 P33261 1/20 0.34
RECQL P46063 1/20 0.34
KMT2A Q03164 1/20 0.34
MAOA P21397 6/20 0.33
GBA1 P04062 1/20 0.33
KDM4E B2RXH2 2/20 0.33
ALDH1A1 P00352 2/20 0.33
HPGD P15428 2/20 0.33
GLA P06280 1/20 0.33
L3MBTL1 Q9Y468 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30161238 1.00 HTR2C (0.34) HTR2CSLC6A4APLNRGAAMEN1
SCHEMBL22010739 0.87 HTR2C (0.34) HTR2CSLC6A4APLNRMEN1NPC1
SCHEMBL29958539 0.87 HTR2C (0.34) HTR2CSLC6A4APLNRMEN1NPC1
SCHEMBL21964000 0.82 MAOA (0.37) GAAMEN1NPC1CYP1A2CYP3A4
SCHEMBL22010512 0.80 GBA1 (0.34) HTR2CSLC6A4GAAMEN1KMT2A
SCHEMBL30161340 0.77 GBA1 (0.33) HTR2CSLC6A4APLNRGAAMAPT
SCHEMBL22010740 0.77 GBA1 (0.33) HTR2CSLC6A4APLNRGAAMAPT
SCHEMBL21963781 0.73 CSF1R (0.32)
SCHEMBL24923419 0.73 MAOA (0.35) GAAMEN1NPC1CYP1A2CYP3A4
SCHEMBL23554740 0.72 ALOX5 (0.45) HTR2CSLC6A4APLNRNPC1MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230035837-A1 ANTIBIOTIC COMPOUNDS, METHODS OF MANUFACTURING THE SAME, PHARMACEUTICAL COMPOSITIONS CONTAINING THE SAME AND USES THEREOF DEBIOPHARM INTERNATIONAL S.A. (CH) 2023-02-02 US disclosed
WO-2020099341-A1 ANTIBIOTIC COMPOUNDS, METHODS OF MANUFACTURING THE SAME, PHARMACEUTICAL COMPOSITIONS CONTAINING THE SAME AND USES THEREOF DEBIOPHARM INTERNATIONAL S.A. (CH) 2020-05-22 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230035837-A1 ANTIBIOTIC COMPOUNDS, METHODS OF MANUFACTURING THE SAME, PHARMACEUTICAL COMPOSITIONS CONTAINING THE SAME AND USES THEREOF GMPS, GNE, GANC HTR2C 3868/4885SLC6A4 4369/4885APLNR 3871/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.